Does VENLAFAXINE Cause Ventricular hypertrophy? 16 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Ventricular hypertrophy have been filed in association with VENLAFAXINE (Venlafaxine Hydrochloride). This represents 0.0% of all adverse event reports for VENLAFAXINE.
16
Reports of Ventricular hypertrophy with VENLAFAXINE
0.0%
of all VENLAFAXINE reports
3
Deaths
3
Hospitalizations
How Dangerous Is Ventricular hypertrophy From VENLAFAXINE?
Of the 16 reports, 3 (18.8%) resulted in death, 3 (18.8%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VENLAFAXINE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does VENLAFAXINE Cause?
Drug ineffective (5,408)
Toxicity to various agents (3,917)
Nausea (2,989)
Completed suicide (2,929)
Headache (2,668)
Dizziness (2,426)
Off label use (2,310)
Overdose (2,220)
Intentional overdose (2,187)
Fatigue (2,153)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which VENLAFAXINE Alternatives Have Lower Ventricular hypertrophy Risk?
VENLAFAXINE vs VENTAVIS
VENLAFAXINE vs VENTOLIN
VENLAFAXINE vs VENTOLIN HFA
VENLAFAXINE vs VERAPAMIL
VENLAFAXINE vs VERICIGUAT